Table 5: The prevalence of intestinal protozoa and helminths among immunocompromised patients.

Reference

No. examined

Immunocompromised patients

% Infected

Protozoa

Helminth

Mahdi, et al. [48]

101

62 Males and 39 females with malignant diseases attending Oncology Centre of Basrah Teaching Hospital. Age 9 months-16 years old.

28.7

10.9

Mahdi & Al-Saadoon [49]

58

Males (37) and females (21) attending the Oncology centre of Basrah Maternity & Child Hospital. Microsporidium was at a rate 10.34% among Hodgkin and

non-hodgkin lymphoma (83.3%)

32.75

0